ARCHIVES

ODAC Member Critical Of Amgen For Price Incentives.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

ASCO Entering Prime Of Life

May 31, 1991

In Brief: William Paul to Head AIDS Research Officer; Schachman Is NIH Extramural Obudsman

February 25, 1994

Concept Approved For New Quality Assurance Center

May 14, 1982

New NCAB Chair Seeks Ideas, Opinions On Cancer Priorities

September 23, 1994

DCE Board Okays New Melanoma Study, Other Concepts

November 11, 1988

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

April 27, 2012